Share
array:23 [ "pii" => "S2253808916000331" "issn" => "22538089" "doi" => "10.1016/j.remnie.2015.09.005" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "749" "copyright" => "Elsevier España, S.L.U. and SEMNIM" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Med Nucl Imagen Mol. 2016;35:171-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2 "PDF" => 2 ] "itemSiguiente" => array:19 [ "pii" => "S2253808916000409" "issn" => "22538089" "doi" => "10.1016/j.remnie.2016.02.004" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "754" "copyright" => "Elsevier España, S.L.U. and SEMNIM" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Med Nucl Imagen Mol. 2016;35:175-85" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 8 "formatos" => array:2 [ "HTML" => 4 "PDF" => 4 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Radiation dose produced by patients during radiopharmaceutical incorporation in nuclear medicine diagnostic procedures" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "175" "paginaFinal" => "185" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dosis de radiación producida por los pacientes durante la incorporación del radiofármaco en las pruebas diagnósticas de medicina nuclear" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1736 "Ancho" => 3201 "Tamanyo" => 239422 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Chronogram of the nuclear medicine diagnostic tests showing the time of radiopharmaceutical incorporation (dark gray), the time the patient was in the imaging equipment (light gray) and the time remaining outside the Department of Nuclear Medicine (black) as well the time of radiopharmaceutical administration (needles) and each dose rate measurement (arrows). The length of the bar indicates the time: median or the measurement or value established in the nuclear medicine procedure (*). The values (time in minutes, except when indicated otherwise) correspond to the range of the measurment or the time fixed in the protocol.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V. Morán, E. Prieto, B. García-García, B. Barbés, M.J. Ribelles, J.Á. Richter, J.M. Martí-Climent" "autores" => array:7 [ 0 => array:2 [ "nombre" => "V." "apellidos" => "Morán" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Prieto" ] 2 => array:2 [ "nombre" => "B." "apellidos" => "García-García" ] 3 => array:2 [ "nombre" => "B." "apellidos" => "Barbés" ] 4 => array:2 [ "nombre" => "M.J." "apellidos" => "Ribelles" ] 5 => array:2 [ "nombre" => "J.Á." "apellidos" => "Richter" ] 6 => array:2 [ "nombre" => "J.M." "apellidos" => "Martí-Climent" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2253654X15001456" "doi" => "10.1016/j.remn.2015.10.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253654X15001456?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808916000409?idApp=UINPBA00004N" "url" => "/22538089/0000003500000003/v2_201703300105/S2253808916000409/v2_201703300105/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S225380891600032X" "issn" => "22538089" "doi" => "10.1016/j.remnie.2015.10.014" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "753" "copyright" => "Elsevier España, S.L.U. and SEMNIM" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Med Nucl Imagen Mol. 2016;35:165-70" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 16 "formatos" => array:2 [ "HTML" => 4 "PDF" => 12 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "The utility of <span class="elsevierStyleSup">18</span>F-FDG PET/CT in solitary fibrous tumors of the pleura" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "165" "paginaFinal" => "170" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilidad de la <span class="elsevierStyleSup">18</span>F-FDG PET/TC en tumores fibrosos solitarios de la pleura" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1331 "Ancho" => 2999 "Tamanyo" => 307491 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Axial CT (A) axial PET (B), axial fused PET/CT (C) scan of malignant solitary fibrous tumor of pleura. A giant, relatively homogenous soft tissue mass in the left hemithorax (arrows). PET/CT images showed high uptake in the left hemithorax (SUV<span class="elsevierStyleInf">max</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>9.8).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Z. Tazeler, G. Tan, A. Aslan, S. Tan" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Z." "apellidos" => "Tazeler" ] 1 => array:2 [ "nombre" => "G." "apellidos" => "Tan" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Aslan" ] 3 => array:2 [ "nombre" => "S." "apellidos" => "Tan" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S225380891600032X?idApp=UINPBA00004N" "url" => "/22538089/0000003500000003/v2_201703300105/S225380891600032X/v2_201703300105/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Patterns of <span class="elsevierStyleSup">11</span>C-PIB cerebral retention in mild cognitive impairment patients" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "171" "paginaFinal" => "174" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "I. Banzo, J.F. Jiménez-Bonilla, I. Martínez-Rodríguez, R. Quirce, M. de Arcocha-Torres, Z. Bravo-Ferrer, C. Lavado-Pérez, P. Sánchez-Juan, E. Rodríguez, M. Jiménez-Alonso, J. López-Defilló, J.M. Carril" "autores" => array:12 [ 0 => array:4 [ "nombre" => "I." "apellidos" => "Banzo" "email" => array:1 [ 0 => "mnubmj@humv.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "J.F." "apellidos" => "Jiménez-Bonilla" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "I." "apellidos" => "Martínez-Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "R." "apellidos" => "Quirce" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "M." "apellidos" => "de Arcocha-Torres" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "Z." "apellidos" => "Bravo-Ferrer" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 6 => array:3 [ "nombre" => "C." "apellidos" => "Lavado-Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "P." "apellidos" => "Sánchez-Juan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 8 => array:3 [ "nombre" => "E." "apellidos" => "Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 9 => array:3 [ "nombre" => "M." "apellidos" => "Jiménez-Alonso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 10 => array:3 [ "nombre" => "J." "apellidos" => "López-Defilló" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 11 => array:3 [ "nombre" => "J.M." "apellidos" => "Carril" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Nuclear Medicine, Molecular Imaging Group (IDIVAL), Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Neurology, IDIVAL, Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Patrones de retención cerebral de <span class="elsevierStyleSup">11</span>C-PIB en pacientes con deterioro cognitivo leve" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 838 "Ancho" => 1598 "Tamanyo" => 102187 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Overall results of <span class="elsevierStyleSup">11</span>C-PIB PET in mild cognitive impairment. MCI, mild cognitive impairment; A, amnestic; NA, non-amnestic.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Based on biomarkers criteria, the prevalence of amyloid pathology in persons with and without dementia has been recently published.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">1,2</span></a> The authors have conducted two meta-analysis to evaluate the presence of cerebral amyloid by PET imaging in persons with risk factors for developing Alzheimer disease (AD) and in a variety of dementia syndromes. They concluded that the PET detection of amyloid cerebral deposition in persons with normal cognition supports the hypothesis that the presence of amyloid defines the first stage of AD.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">2</span></a> Moreover, in the clinical practice, the authors emphasize the role of PET imaging for the demonstration of amyloid in the diagnosis of AD in patients with different degrees of cognitive impairment.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Mild cognitive impairment (MCI) is currently considered an intermediate phase of cognition decline that precede the clinical onset of AD. In the clinical setting, MCI patients can be categorized as amnestic MCI (A-MCI) and non-amnestic MCI (NA-MCI). It is well known that patients with A-MCI have a risk to develop dementia. However, clinical evolution of each MCI subgroup (A-MCI and NA-MCI) is different in terms of risk of conversion to AD.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">3</span></a> The progress to AD of patients with A-MCI is about 12% per year, and up to 80% of these patients will develop AD in a period of 6 years.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">4</span></a> In previous studies, we have reported a different behavior of <span class="elsevierStyleSup">11</span>C-PIB accumulation between A-MCI and NA-MCI patients.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">5,6</span></a> All the NA-MCI patients presented negative <span class="elsevierStyleSup">11</span>C-PIB PET/CT scans. Nevertheless, 74% of the A-MCI patients demonstrated <span class="elsevierStyleSup">11</span>C-PIB cerebral retention. This observation allowed us to suggest an elevated risk of conversion to AD in A-MCI patients.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Normally, <span class="elsevierStyleSup">11</span>C-PIB PET/CT scans are reported in terms of dual-report.<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">7–9</span></a> Negative scan if only unspecific uptake in the white matter is observed, and positive scan if cortical amyloid deposition is detected regardless of its distribution. In the study of patients with cognitive impairment, we have observed several <span class="elsevierStyleSup">11</span>C-PIB cerebral patterns. Among them the most frequently and commonly found were either predominant retention in anterior regions of the brain (frontal, anterior cingulate, lateral temporal, basal ganglia) and the generalized retention in all cerebral regions.</p><p id="par0020" class="elsevierStylePara elsevierViewall">To the best of our knowledge, this issue has not been addressed before. Thus, we have carried out this work to present the distribution patterns of cerebral amyloid detected by <span class="elsevierStyleSup">11</span>C-PIB PET/CT scan in A-MCI and NA-MCI patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Study population</span><p id="par0025" class="elsevierStylePara elsevierViewall">All MCI patients were submitted by the Cognitive Impairment Unit of the hospital. The study included 69 patients, 37 male and 32 female. The average age was 67.5 years (range 42–79 years). All patients underwent a complete neurological evaluation, including medical history, physical examination, blood chemistry measurements, and neuroimaging (CT or MR). Neurological study of the cognitive function included screening tests (MMSE, T@M, and clock test) and neurophysiological evaluation of different cognitive areas (verbal and visual episodic memory, semantic knowledge, language, attention, executive function, praxis, and visuospatial abilities). Signed informed consent was obtained from each patient. All procedures were approved by the ethical committee of the University Hospital.</p><p id="par0030" class="elsevierStylePara elsevierViewall">According to the clinical and neurophysiological evaluations, MCI patients were sub-classified as A-MCI (53 patients) and NA-MCI (16 patients). Patients with A-MCI had just one impairment in the memory domain or impairment in the memory domain associated with one or more impairment in other domains, such as attention, language, executive function, and visuospatial processing. Patients with NA-MCI had impairment in one or more nonmemory domains and no memory deficits.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080"><span class="elsevierStyleSup">11</span>C-PIB synthesis</span><p id="par0035" class="elsevierStylePara elsevierViewall">The radiosynthesis of <span class="elsevierStyleSup">11</span>C-PIB was performed in the Department of Nuclear Medicine of the hospital. <span class="elsevierStyleSup">11</span>C-PIB was synthesized using the one-step <span class="elsevierStyleSup">11</span>C-methyl triflate approach. The full process of synthesis has been described elsewhere.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a> The final administered product contained 0.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.28<span class="elsevierStyleHsp" style=""></span>μg of PIB. The specific activity was 138<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>35<span class="elsevierStyleHsp" style=""></span>GBq/μmol and the radiochemical purity was higher than 99%.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Image acquisition</span><p id="par0040" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSup">11</span>C-PIB PET/CT scans were acquired on a Siemens Biograph LSO Pico 3D equipment (Siemens Healthcare Molecular Imaging, Hoffman Estates, IL, USA). Twenty minutes before the intravenous administration of the radiotracer, the patients rested in supine position in a quiet room, dimly lit. All patients underwent a 30<span class="elsevierStyleHsp" style=""></span>min static scan at 60–90<span class="elsevierStyleHsp" style=""></span>min after injection. The information provided by CT was used for the attenuation correction of the PET scan. Iterative reconstruction of the images was performed using an ordered subsets expectation maximization algorithm. The axial slices were reoriented parallel to the frontal–occipital axis.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Image analysis</span><p id="par0045" class="elsevierStylePara elsevierViewall">Axial slices of <span class="elsevierStyleSup">11</span>C-PIB study were displayed with a color and gray scales. The cerebral distribution of <span class="elsevierStyleSup">11</span>C-PIB on sagittal and coronal slices was not evaluated. Visual analysis of the studies was performed by two experienced nuclear medicine physicians. The observers were unaware of diagnosis and any other clinical data. <span class="elsevierStyleSup">11</span>C-PIB images were considered positive when cortical retention of the radiotracer was observed. <span class="elsevierStyleSup">11</span>C-PIB images were considered negative if only nonspecific white matter uptake was observed. According to regions involved, <span class="elsevierStyleSup">11</span>C-PIB cortical retention was classified into A-pattern and B-pattern. The A-pattern described a predominant retention in frontal, anterior cingulate, lateral temporal, and basal ganglia. On the other hand, the B-pattern was assigned when a generalized cortical retention was detected (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Statistical analysis</span><p id="par0050" class="elsevierStylePara elsevierViewall">Categorical differences were expressed as frequencies and were compared with the Fisher exact test for independent samples. Statistical analysis was performed using SPSS, version 15 for windows. Statistical significance was established at <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>0.05.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><p id="par0055" class="elsevierStylePara elsevierViewall">Overall, 39 of the 69 patients (56%) showed a positive <span class="elsevierStyleSup">11</span>C-PIB PET/CT scan; the remaining 30 patients (44%) presented a negative scan. Based on the clinical assessment, 53 out of 69 patients had a diagnosis of A-MCI and the other 16 patients were NA-MCI (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Of the 53 A-MCI patients, 36 (68%) showed positive <span class="elsevierStyleSup">11</span>C-PIB scans, whereas 17 (32%) had negative scans (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). Regarding the distribution of the <span class="elsevierStyleSup">11</span>C-PIB cortical retention, 11 out of 36 (30%) positive scans in the group of A-MCI showed A-pattern and in the remaining 25 (70%) patients, B-pattern was detected.</p><p id="par0065" class="elsevierStylePara elsevierViewall">For the 16 patients with a diagnosis of NA-MCI, positive <span class="elsevierStyleSup">11</span>C-PIB scans were observed in 3 patients (19%) and negative scans in the other 13 patients (81%) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). Regional distribution in the 3 positive <span class="elsevierStyleSup">11</span>C-PIB scans showed A-pattern in 1 (33%) and B-pattern in 2 cases (67%).</p><p id="par0070" class="elsevierStylePara elsevierViewall">Therefore, A-pattern was found in 12 out of 39 (31%) positive <span class="elsevierStyleSup">11</span>C-PIB scans and B-pattern in the remaining 27 (69%) positive scans.</p><p id="par0075" class="elsevierStylePara elsevierViewall">When the group of A-MCI patients was compared with the group of NA-MCI patients, statistically significant differences in <span class="elsevierStyleSup">11</span>C-PIB brain retention were found (36/53 vs. 3/16; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001).</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Discussion</span><p id="par0080" class="elsevierStylePara elsevierViewall">In the present study we found that 56% of patients with MCI had cortical retention of <span class="elsevierStyleSup">11</span>C-PIB in the brain. This finding is similar to previous reports<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">3,10,11</span></a> and represents the prevalence of amyloid deposition detected by <span class="elsevierStyleSup">11</span>C-PIB PET in patients with MCI. Many studies have documented that AD showed higher cortical retention of <span class="elsevierStyleSup">11</span>C-PIB than healthy controls.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">9,12</span></a> All this cumulative evidence with amyloid imaging led to recommend its use in the clinical decision-making process by the current guidelines on diagnostic criteria for studying dementia patients.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">13,14</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">In MCI patients, <span class="elsevierStyleSup">11</span>C-PIB PET has demonstrated in vivo an increased cerebral amyloid burden.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">3,15–17</span></a> This fact is remarkable. Forsberg et al. documented that 33% (7/21) of MCI patients with positive <span class="elsevierStyleSup">11</span>C-PIB PET converted to AD during clinical follow-up (8.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.0 months).<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">17</span></a> In other study, Okello et al. reported that 82% of patients with MCI and positive <span class="elsevierStyleSup">11</span>C-PIB converted to AD within 3 years of baseline PET study; and, in addition, they observed a fast conversion to AD within 1 year in half (47%) of the <span class="elsevierStyleSup">11</span>C-PIB positive patients.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">3</span></a> Thus, the demonstration of cerebral amyloid using <span class="elsevierStyleSup">11</span>C-PIB in MCI patients can identify a group o patients at increased risk of developing AD.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">18,19</span></a> On the other hand, we have obtained negative <span class="elsevierStyleSup">11</span>C-PIB studies in 44% of MCI patients included in our study. This observation would mean that AD could be excluded almost in a half of the population with MCI.</p><p id="par0090" class="elsevierStylePara elsevierViewall">The cerebral presence of <span class="elsevierStyleSup">11</span>C-PIB deserves an analysis when MCI patients are sub-classified into A-MCI and NA-MCI. We found higher proportion of positive <span class="elsevierStyleSup">11</span>C-PIB in A-MCI patients (68%) than NA-MCI patients (32%). Significant difference (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001) between the 2 subgroups was obtained. This observation was in accordance with previous reports.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">20–22</span></a> In this sense, Lee et al. reported 62% <span class="elsevierStyleSup">11</span>C-PIB positive A-MCI patients.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">20</span></a> Meanwhile, Lowe et al. observed significant discrimination (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05) between A-MCI and NA-MCI by <span class="elsevierStyleSup">11</span>C-PIB PET.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">21</span></a> Other authors have mentioned that the increased <span class="elsevierStyleSup">11</span>C-PIB uptake in prefrontal, cingulate and parietal regions is higher in AD compared to MCI or control subjects.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">22</span></a> Moreover, <span class="elsevierStyleSup">11</span>C-PIB uptake in MCI may be different than in controls only in prefrontal cortex.<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">11,21</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">In most of the published work<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">7–9</span></a> the visual assessment of the <span class="elsevierStyleSup">11</span>C-PIB cortical retention was based on positive/negative criteria. However, we observed the frequent detection of two differentiated patterns of regional cerebral retention of <span class="elsevierStyleSup">11</span>C-PIB in the MCI population included. Taking into account these distribution patterns, and in accordance with other authors,<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">15,23</span></a> our study shows a variable distribution of <span class="elsevierStyleSup">11</span>C-PIB cerebral retention in MCI patients, and this would allow to hypothesize on the value of these patterns for a better characterization of MCI patients.</p><p id="par0100" class="elsevierStylePara elsevierViewall">The A-pattern of predominant cerebral retention in frontal, anterior cingulate, lateral temporal, and basal ganglia was detected in 31% of PIB-positive MCI patients (30% of A-MCI and 33% of NA-MCI). In the first human study using <span class="elsevierStyleSup">11</span>C-PIB PET in AD patients, Klunk et al. already observed, in his research work, a prominent increase of <span class="elsevierStyleSup">11</span>C-PIB retention in frontal, parietal, temporal and occipital cortex and in striatum.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">12</span></a> Posteriorly, other authors have reported similar findings.<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">23–27</span></a> Interestingly, there is a correlation between the severity of dementia and the specific increased <span class="elsevierStyleSup">11</span>C-PIB retention in the anterior regions of the brain, including both putamina.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">27</span></a> In our experience, and excluding the <span class="elsevierStyleSup">11</span>C-PIB accumulation in the basal ganglia, the A-pattern would resemble the early neuropathological changes of cerebral amyloid deposits identified at autopsy from demented subjects.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">28</span></a> The B-pattern of generalized <span class="elsevierStyleSup">11</span>C-PIB cerebral retention was detected in 69% of PIB-positive MCI patients (70% of A-MCI and 67% of NA-MCI). This B-pattern was twice more frequently observed than A-pattern. The clinical relevance of this finding would be the identification of patients at an early stage of disease, represented by A-pattern, where treatments to control the disease progression would be desirable and potentially effective. From a pathological point of view, B-pattern is consistent with the extensive deposit of amyloid plaques in all cerebral cortical areas revealed in post-mortem studies and represent the end-stage of histological amyloid accumulation as mentioned by Braak et al.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">28</span></a> We think that both distribution patterns support the hypothesis of the clinical–pathological continuum of AD dementia.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">29</span></a> In the clinical setting of MCI patients, the A-pattern would represent a low and variable <span class="elsevierStyleSup">11</span>C-PIB uptake at the initial period of amyloid accumulation affecting heterogenous regions of the brain, whereas the B-pattern would represent a high and diffuse <span class="elsevierStyleSup">11</span>C-PIB uptake and, therefore, a more advanced stage of the disease.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Limitations</span><p id="par0105" class="elsevierStylePara elsevierViewall">The work was conducted in a university hospital and the participants were clinically selected at a single cognitive impairment unit. This fact may limit the generalization of the results. The sample size of A-MCI group was relatively large. However, the sample size of NA-MCI patients was too small to detect significant differences between the 2 patterns of cerebral <span class="elsevierStyleSup">11</span>C-PIB deposition. We performed a visual analysis of images what it is accordance with the clinical daily practice. However, other authors used image co-registration with MR imaging to delineate regions of interest and automated or semi-automated software for data quantification. Although these methods allow the regional quantification of <span class="elsevierStyleSup">11</span>C-PIB retention, its use is not standardized and requires a previous process of validation. Further investigations and longitudinal studies may help to elucidate the clinical outcome and the possibility to detect changes in the cerebral <span class="elsevierStyleSup">11</span>C-PIB distribution of patients presenting A-pattern.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conclusion</span><p id="par0110" class="elsevierStylePara elsevierViewall">In positive <span class="elsevierStyleSup">11</span>C-PIB MCI patients, two distinctive patterns of distribution may be identified: predominant retention in the anterior cerebral regions and generalized retention. Positive <span class="elsevierStyleSup">11</span>C-PIB studies were more frequent in A-MCI than in NA-MCI patients. Negative <span class="elsevierStyleSup">11</span>C-PIB studies can be obtained in almost half of MCI patients. Visual assessment of <span class="elsevierStyleSup">11</span>C-PIB images allows a clear distinction between positive <span class="elsevierStyleSup">11</span>C-PIB patterns and negative <span class="elsevierStyleSup">11</span>C-PIB studies. The recognition of these distribution patterns of <span class="elsevierStyleSup">11</span>C-PIB cerebral retention provides a characterization of MCI patients.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflict of interest</span><p id="par0115" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres821696" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec818681" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres821697" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusión" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec818682" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study population" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "C-PIB synthesis" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Image acquisition" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Image analysis" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Statistical analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0040" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0045" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0050" "titulo" => "Limitations" ] 9 => array:2 [ "identificador" => "sec0055" "titulo" => "Conclusion" ] 10 => array:2 [ "identificador" => "sec0060" "titulo" => "Conflict of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-08-07" "fechaAceptado" => "2015-09-28" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec818681" "palabras" => array:6 [ 0 => "Mild cognitive impairment" 1 => "Alzheimer disease" 2 => "Dementia" 3 => "Amyloid imaging" 4 => "<span class="elsevierStyleSup">11</span>C-PIB" 5 => "Positron emission tomography" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec818682" "palabras" => array:6 [ 0 => "Deterioro cognitivo leve" 1 => "Enfermedad de Alzheimer" 2 => "Demencia" 3 => "Imagen amiloide" 4 => "<span class="elsevierStyleSup">11</span>C-PIB" 5 => "Tomografía por emisión de positrones" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To evaluate the patterns of cerebral cortical distribution of <span class="elsevierStyleSup">11</span>C-PIB in patients with mild cognitive impairment (MCI).</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Material and methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The study included 69 patients (37 male, age range 42–79 years) with MCI, sub-classified as 53 with amnestic-MCI (A-MCI), and 16 with non-amnestic-MCI (NA-MCI). Patients underwent <span class="elsevierStyleSup">11</span>C-PIB PET/CT scan 60<span class="elsevierStyleHsp" style=""></span>min after intravenous injection of the radiotracer. A visual analysis of the images was performed by 2 experienced physicians. <span class="elsevierStyleSup">11</span>C-PIB-positive studies were considered when gray matter uptake was equal to or greater than white matter. According to the regions involved, <span class="elsevierStyleSup">11</span>C-PIB-positive studies were classified into A-pattern (predominant retention in frontal, anterior cingulate, lateral temporal, and basal ganglia) and B-pattern (generalized retention).</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Thirty-nine of the 69 (56%) patients with MCI showed <span class="elsevierStyleSup">11</span>C-PIB retention. Of the 53 A-MCI patients, 36 (68%) showed <span class="elsevierStyleSup">11</span>C-PIB retention. Eleven out of 36 (30%) positive scans in A-MCI patients showed A-pattern, and 25 out of 36 (70%) patients had a B-pattern. Positive <span class="elsevierStyleSup">11</span>C-PIB was observed in 3 out of 16 (19%) patients with NA-MCI. Regional distribution in these 3 patients showed A-pattern in 1, and B-pattern in 2 patients.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Cortical retention of <span class="elsevierStyleSup">11</span>C-PIB was more frequent in A-MCI than in NA-MCI patients, and also B-pattern than A-pattern in the <span class="elsevierStyleSup">11</span>C-PIB positive group. The recognition of <span class="elsevierStyleSup">11</span>C-PIB distribution patterns allows MCI patients to be classified, and the A-pattern may offer a therapeutic window for potential future treatments.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Evaluar los patrones de distribución cortical cerebral de <span class="elsevierStyleSup">11</span>C-PIB en pacientes con deterioro cognitivo leve (DCL).</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Material y métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El estudio incluyó 69 pacientes (37 varones, rango de edad 42–79 años) con DCL, que fueron clasificados en 53 DCL amnésico (DCL-A) y 16 DCL no amnésico (DCL-NA). Se obtuvo una PET/TC <span class="elsevierStyleSup">11</span>C-PIB 60<span class="elsevierStyleHsp" style=""></span>min después de la inyección intravenosa del radiotrazador. Se realizó un análisis visual de las imágenes por 2 médicos con experiencia. Los estudios <span class="elsevierStyleSup">11</span>C-PIB se consideraron positivos cuando la captación en la sustancia gris fue igual o superior a la captación en la sustancia blanca. Dependiendo de las regiones afectadas, los estudios <span class="elsevierStyleSup">11</span>C-PIB positivos se clasificaron en patrón A (retención predominante en frontal, cingulado anterior, lateral temporal y ganglios basales) y patrón B (retención generalizada).</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">De los 69 pacientes con DCL, 39 (56%) mostraron retención de <span class="elsevierStyleSup">11</span>C-PIB. De los 53 pacientes DCL-A, 36 (68%) tuvieron retención cerebral de <span class="elsevierStyleSup">11</span>C-PIB. Once de los 36 (30%) estudios positivos en los pacientes DCL-A mostraron un patrón A y 25 de los 36 (70%) pacientes presentaron un patrón B. Se observaron estudios <span class="elsevierStyleSup">11</span>C-PIB positivos en 3 de los 16 (19%) pacientes con DCL-NA. En estos 3 pacientes la distribución regional mostró patrón A en uno y patrón B en 2 pacientes.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusión</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La retención cortical de <span class="elsevierStyleSup">11</span>C-PIB fue más frecuente en pacientes con DCL-A que en pacientes con DCL-NA, y, asimismo, el patrón B que el patrón A en el grupo <span class="elsevierStyleSup">11</span>C-PIB positivo. La identificación de los patrones de distribución de <span class="elsevierStyleSup">11</span>C-PIB permite una caracterización de los pacientes con DCL; el patrón A puede ofrecer una ventana para potenciales tratamientos en el futuro.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusión" ] ] ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1013 "Ancho" => 2504 "Tamanyo" => 209750 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Patterns of <span class="elsevierStyleSup">11</span>C-PIB PET. (A) Negative study. (B) Predominant retention in frontal, anterior cingulate, lateral temporal, and basal ganglia (A-pattern). (C) Generalized retention (B-pattern).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 838 "Ancho" => 1598 "Tamanyo" => 102187 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Overall results of <span class="elsevierStyleSup">11</span>C-PIB PET in mild cognitive impairment. MCI, mild cognitive impairment; A, amnestic; NA, non-amnestic.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib0150" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Ossenkoppele" 1 => "W.J. Jansen" 2 => "G.D. Rabinovici" 3 => "D.L. Knol" 4 => "W.M. van der Flier" 5 => "B.N.M. van Berckel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2015.4669" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2015" "volumen" => "313" "paginaInicial" => "1939" "paginaFinal" => "1949" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25988463" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0155" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.J. Jansen" 1 => "R. Ossenkoppele" 2 => "D.L. Knol" 3 => "B.M. Tijms" 4 => "P. Scheltens" 5 => "F.R.J. Verhey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2015.4668" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2015" "volumen" => "313" "paginaInicial" => "1924" "paginaFinal" => "1938" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25988462" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0160" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Conversion of amyloid positive and negative MCI to AD over 3 years: an <span class="elsevierStyleSup">11</span>C-PIB PET study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Okello" 1 => "J. Koivunen" 2 => "P. Edison" 3 => "H.A. Archer" 4 => "F.E. Turkheimer" 5 => "K. Någren" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0b013e3181b23564" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2009" "volumen" => "73" "paginaInicial" => "754" "paginaFinal" => "760" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19587325" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0165" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mild cognitive impairment: clinical characterization and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.C. Petersen" 1 => "G.E. Smith" 2 => "S.C. Waring" 3 => "R.J. Ivnik" 4 => "E.G. Tangalos" 5 => "E. Kommen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "1999" "volumen" => "56" "paginaInicial" => "303" "paginaFinal" => "308" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10190820" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0170" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Banzo" 1 => "J. Jiménez-Bonilla" 2 => "F. Ortega-Nava" 3 => "R. Quirce" 4 => "I. Martínez-Rodríguez" 5 => "M. de Arcocha-Torres" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MNM.0000000000000042" "Revista" => array:6 [ "tituloSerie" => "Nucl Med Commun" "fecha" => "2014" "volumen" => "35" "paginaInicial" => "238" "paginaFinal" => "244" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24240196" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0175" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amyloid imaging with <span class="elsevierStyleSup">11</span>C-PIB in patients with cognitive impairment in a clinical setting. A visual and semiquantitative analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.F. Jiménez-Bonilla" 1 => "I. Banzo" 2 => "M. de Arcocha-Torres" 3 => "R. Quirce" 4 => "I. Martínez-Rodríguez" 5 => "P. Sánchez-Juan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/RLU.0000000000000934" "Revista" => array:2 [ "tituloSerie" => "Clin Nucl Med" "fecha" => "2015" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0180" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Brain amyloid imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.C. Rowe" 1 => "V.L. Villemagne" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2967/jnumed.110.076315" "Revista" => array:6 [ "tituloSerie" => "J Nucl Med" "fecha" => "2011" "volumen" => "52" "paginaInicial" => "1733" "paginaFinal" => "1740" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21917849" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0185" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multimodality imaging of Alzheimer disease and other neurodegenerative dementias" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I.M. Nasrallah" 1 => "D.A. Wolk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2967/jnumed.114.141416" "Revista" => array:7 [ "tituloSerie" => "J Nucl Med" "fecha" => "2014" "volumen" => "55" "paginaInicial" => "2003" "paginaFinal" => "2011" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25413136" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002914914010467" "estado" => "S300" "issn" => "00029149" ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0190" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Practical utility of amyloid and FDG-PET in an academic dementia center" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Sánchez-Juan" 1 => "P.M. Ghosh" 2 => "J. Hagen" 3 => "B. Gesierich" 4 => "M. Henry" 5 => "L.T. Grinberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0000000000000032" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2014" "volumen" => "82" "paginaInicial" => "230" "paginaFinal" => "238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24353340" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0195" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imaging beta-amyloid burden in aging and dementia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.C. Rowe" 1 => "S. Ng" 2 => "U. Ackermann" 3 => "S.J. Gong" 4 => "K. Pike" 5 => "G. Savage" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000261919.22630.ea" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2007" "volumen" => "68" "paginaInicial" => "1718" "paginaFinal" => "1725" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17502554" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0200" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amyloid imaging in mild cognitive impairment subtypes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.A. Wolk" 1 => "J.C. Price" 2 => "J.A. Saxton" 3 => "B.E. Snitz" 4 => "J.A. James" 5 => "O.L. López" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.21598" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2009" "volumen" => "65" "paginaInicial" => "557" "paginaFinal" => "568" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19475670" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0205" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imaging brain amyloid in Alzheimer's disease and Pittsburgh compound-B" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.E. Klunk" 1 => "H. Engler" 2 => "A. Nordberg" 3 => "Y. Wang" 4 => "G. Blomqvist" 5 => "D.P. Holt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.20009" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2004" "volumen" => "55" "paginaInicial" => "306" "paginaFinal" => "319" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14991808" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0210" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid imaging task force of the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.A. Johnson" 1 => "S. Minoshima" 2 => "N.I. Bohnen" 3 => "K.J. Donohoe" 4 => "N.L. Foster" 5 => "P. Herscovitch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Alzheimer's Dement" "fecha" => "2013" "volumen" => "9" "paginaInicial" => "e106" "paginaFinal" => "e109" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0215" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Dubois" 1 => "H.H. Feldman" 2 => "C. Jacova" 3 => "H. Hampel" 4 => "J.L. Molinuevo" 5 => "K. Blennow" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(14)70090-0" "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2014" "volumen" => "13" "paginaInicial" => "614" "paginaFinal" => "629" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24849862" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0220" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PET amyloid ligand [<span class="elsevierStyleSup">11</span>C]PIB uptake is increased in mild cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N.M. Kemppainen" 1 => "S. Aalto" 2 => "I.A. Wilson" 3 => "K. Någren" 4 => "S. Helin" 5 => "A. Brück" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000260969.94695.56" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2007" "volumen" => "68" "paginaInicial" => "1603" "paginaFinal" => "1606" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17485647" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0225" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PET amyloid ligand [<span class="elsevierStyleSup">11</span>C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Koivunen" 1 => "T. Pirttilä" 2 => "N. Kemppainen" 3 => "S. Aalto" 4 => "S.K. Herukka" 5 => "A.M. Jauhianen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000163927" "Revista" => array:6 [ "tituloSerie" => "Dement Geriatr Cogn Disord" "fecha" => "2008" "volumen" => "26" "paginaInicial" => "378" "paginaFinal" => "383" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18931497" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0230" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PET imaging of amyloid deposition in patients with mild cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Forsberg" 1 => "H. Engler" 2 => "O. Almkvist" 3 => "G. Blomquist" 4 => "G. Hagman" 5 => "A. Wall" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2007.03.029" "Revista" => array:6 [ "tituloSerie" => "Neurobiol Aging" "fecha" => "2008" "volumen" => "29" "paginaInicial" => "1456" "paginaFinal" => "1465" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17499392" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0235" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current concepts in mild cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.C. Petersen" 1 => "R. Doody" 2 => "A. Kurz" 3 => "R.C. Mohs" 4 => "J.C. Morris" 5 => "P.V. Rabins" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2001" "volumen" => "58" "paginaInicial" => "1985" "paginaFinal" => "1992" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11735772" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0240" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mild cognitive impairment risk of Alzheimer disease and rate of cognitive decline" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.A. Boyle" 1 => "R.S. Wilson" 2 => "N.T. Aggarwal" 3 => "Y. Tang" 4 => "D.A. Bennett" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/01.wnl.0000228244.10416.20" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2006" "volumen" => "67" "paginaInicial" => "441" "paginaFinal" => "445" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16894105" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0245" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Lee" 1 => "S.W. Seo" 2 => "D.L. Na" 3 => "C. Kim" 4 => "J.H. Park" 5 => "G.H. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamapsychiatry.2013.4506" "Revista" => array:6 [ "tituloSerie" => "JAMA Psychiatry" "fecha" => "2014" "volumen" => "71" "paginaInicial" => "412" "paginaFinal" => "422" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24554306" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0250" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of <span class="elsevierStyleSup">18</span>F-FDG and PIB-PET in cognitive impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V.J. Lowe" 1 => "B.J. Kemp" 2 => "C.R. Jack Jr." 3 => "M. Senjem" 4 => "S. Weigand" 5 => "M. Shiung" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2967/jnumed.108.058529" "Revista" => array:6 [ "tituloSerie" => "J Nucl Med" "fecha" => "2009" "volumen" => "50" "paginaInicial" => "878" "paginaFinal" => "886" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19443597" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0255" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pittsburgh compound B (<span class="elsevierStyleSup">11</span>C-PIB) and fluorodeoxyglucose (<span class="elsevierStyleSup">18</span>F-FDG) PET in patients with Alzheimer's disease, mild cognitive impairment, and healthy controls" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.P. Devanand" 1 => "A. Mikhno" 2 => "G.H. Pelton" 3 => "K. Cuasay" 4 => "G. Pradhaban" 5 => "J.S.D. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Geriartr Psychiatry Neurol" "fecha" => "2010" "volumen" => "23" "paginaInicial" => "185" "paginaFinal" => "198" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0260" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Apperance modeling of <span class="elsevierStyleSup">11</span>C PIB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Fripp" 1 => "P. Bourgeat" 2 => "O. Acosta" 3 => "P. Raniga" 4 => "M. Modat" 5 => "K.E. Pike" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroimage.2008.07.053" "Revista" => array:6 [ "tituloSerie" => "Neuroimage" "fecha" => "2008" "volumen" => "43" "paginaInicial" => "430" "paginaFinal" => "439" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18789389" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0265" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Visual assessment versus quantitative assessment of <span class="elsevierStyleSup">11</span>C-PIB PET and <span class="elsevierStyleSup">18</span>F-FDG PET for detection of Alzheimer's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Ng" 1 => "V.L. Villemagne" 2 => "S. Berlangieri" 3 => "S.T. Lee" 4 => "M. Cherk" 5 => "S.J. Gong" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Nucl Med" "fecha" => "2007" "volumen" => "48" "paginaInicial" => "547" "paginaFinal" => "552" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17401090" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0270" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Li" 1 => "J.O. Rinne" 2 => "L. Mosconi" 3 => "E. Pirraglia" 4 => "H. Rusinek" 5 => "S. DeSanti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00259-008-0833-y" "Revista" => array:6 [ "tituloSerie" => "Eur J Nucl Med Mol Imaging" "fecha" => "2008" "volumen" => "35" "paginaInicial" => "2169" "paginaFinal" => "2181" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18566819" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0275" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Drzezga" 1 => "T. Grimmer" 2 => "G. Henriksen" 3 => "I. Stangier" 4 => "R. Perneczky" 5 => "J. Diehl-Schmid" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neuroimage.2007.09.020" "Revista" => array:6 [ "tituloSerie" => "Neuroimage" "fecha" => "2008" "volumen" => "39" "paginaInicial" => "619" "paginaFinal" => "633" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17962045" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0280" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical severity of Alzheimer's disease is associated with PIB uptake in PET" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Grimmer" 1 => "G. Henriksen" 2 => "H.U. Wester" 3 => "H. Forstl" 4 => "W.E. Klunk" 5 => "C.A. Mathis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.neurobiolaging.2008.01.016" "Revista" => array:6 [ "tituloSerie" => "Neurobiol Aging" "fecha" => "2009" "volumen" => "30" "paginaInicial" => "1902" "paginaFinal" => "1909" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18346821" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0285" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuropathological stageing of Alzheimer-related changes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Braak" 1 => "E. Braak" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Neuropathol" "fecha" => "1991" "volumen" => "82" "paginaInicial" => "239" "paginaFinal" => "259" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1759558" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0290" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.A. Sperling" 1 => "P.S. Aisen" 2 => "L.A. Beckett" 3 => "D.A. Bennett" 4 => "S. Craft" 5 => "A.M. Fagan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Alzheimer's Dement" "fecha" => "2011" "volumen" => "7" "paginaInicial" => "280" "paginaFinal" => "292" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22538089/0000003500000003/v2_201703300105/S2253808916000331/v2_201703300105/en/main.assets" "Apartado" => array:4 [ "identificador" => "7926" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22538089/0000003500000003/v2_201703300105/S2253808916000331/v2_201703300105/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2253808916000331?idApp=UINPBA00004N" ]
